Phase I Study of Safety and Persistence of UC-781 Vaginal Microbicide
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
Vaginal microbicides are compounds that may protect women from HIV and other sexually
transmitted infections (STIs). This study will determine the safety of the microbicide UC-781
by comparing the effects of keeping the microbicide in the vagina for different lengths of
time.
Phase:
Phase 1
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)